|
Volumn 33, Issue 4, 1998, Pages 392-395
|
High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer
a a a a a a a
a
INSTITUT CURIE
(France)
|
Author keywords
Bladder neoplasms; Brain neoplasms, secondary; Drug therapy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
METHOTREXATE;
VINBLASTINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BLADDER CARCINOMA;
BRAIN METASTASIS;
CANCER SURVIVAL;
CLINICAL ARTICLE;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
REMISSION;
SURVIVAL TIME;
TRANSITIONAL CELL CARCINOMA;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN NEOPLASMS;
CARCINOMA, TRANSITIONAL CELL;
CISPLATIN;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
METHOTREXATE;
MIDDLE AGED;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
URINARY BLADDER NEOPLASMS;
VINBLASTINE;
|
EID: 0031981303
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019622 Document Type: Article |
Times cited : (37)
|
References (12)
|